TY - JOUR
T1 - Factors associated with receipt of hematopoietic cell transplantation for acute lymphoblastic leukemia
AU - Manikkam Umakanthan, Jayadev
AU - Chen, Baojiang
AU - Gundabolu, Krishna
AU - Bhatt, Vijaya R.
N1 - Publisher Copyright:
© 2018 Future Medicine Ltd.
PY - 2018/6
Y1 - 2018/6
N2 - Aim: To evaluate practice patterns of hematopoietic cell transplantation (HCT) for acute lymphoblastic leukemia. Materials & methods: We utilized the National Cancer Database to extract patient-level data of adults (aged 18-80 years) diagnosed with acute lymbhoblastic leukemia between 2003 and 2012. We performed multivariable logistic regression to determine variables associated with the use of HCT. Results: Out of a total of 11,871 patients, 12.7% received HCT. In a multivariate analysis, older age, male sex, higher Charlson co-morbidity score, nonacademic treatment center, poor education and Medicare/Medicaid or no insurance were associated with lower likelihood of receiving HCT. Conclusion: Our study demonstrates variations in the utilization of HCT based on socioeconomic and health system factors.
AB - Aim: To evaluate practice patterns of hematopoietic cell transplantation (HCT) for acute lymphoblastic leukemia. Materials & methods: We utilized the National Cancer Database to extract patient-level data of adults (aged 18-80 years) diagnosed with acute lymbhoblastic leukemia between 2003 and 2012. We performed multivariable logistic regression to determine variables associated with the use of HCT. Results: Out of a total of 11,871 patients, 12.7% received HCT. In a multivariate analysis, older age, male sex, higher Charlson co-morbidity score, nonacademic treatment center, poor education and Medicare/Medicaid or no insurance were associated with lower likelihood of receiving HCT. Conclusion: Our study demonstrates variations in the utilization of HCT based on socioeconomic and health system factors.
KW - acute lymphoblastic leukemia
KW - healthcare disparities
KW - hematopoietic cell transplant
KW - transplant utilization
UR - http://www.scopus.com/inward/record.url?scp=85048048721&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85048048721&partnerID=8YFLogxK
U2 - 10.2217/fon-2017-0599
DO - 10.2217/fon-2017-0599
M3 - Article
C2 - 29712491
AN - SCOPUS:85048048721
SN - 1479-6694
VL - 14
SP - 1253
EP - 1260
JO - Future Oncology
JF - Future Oncology
IS - 13
ER -